Tuesday, 15 December 2015 09:42

33rd International Vicenza Course on Critical Care Nephrology: Presentation Collection

By 
Rate this item
(1 Vote)

vicenza course

 

33rd International Vicenza Course on Critical Care Nephrology

Opening Ceremony

  • Critical Care Nephrology from origin to today - C. Ronco
  • Anecdotes in Critical Care Nephrology - J. Kellum

Session 1: Epidemiology of AKI 

  • AKI Classification and the Conceptual Model of AKI - J. Kellum
  • Epidemiology and Outcomes of AKI in Hospital and ICU - E. Hoste
  • Incidence and Outcomes of AKI in Sepsis and MOF - R. Bellomo
  • Incidence and Outcomes of AKI in Cardiac Surgery - N. Katz
  • Risk Factors for AKI in Hospital and ICU - M. Rosner

Session 2: AKI - ICT and Economics, Debate on Renal Angina

  • Electronic Records & Sniffers - K. Kashani
  • The Health Economics of AKI - A. Lewington
  • Renal Angina: New Concept, Perfect Term - L.S. Chawla

Session 3: RRT in AKI and Critical Illness

  • Evolution of Technology in CRRT - C. Ronco
  • Renal Remplacement Therapy: When to start in AKI - S. Bagshaw
  • Clinical Indications and Patient Selection - R. Mehta
  • Treatment Modality Selection - A. Tolwani
  • How and why do filters clot? - R. Bellomo

Session 4: Multiple Organ Support Therapies

  • Extracorporeal Ultrafiltration for Heart Failure - C. Ronco
  • Extracorporeal CO2 Removal - C. Ronco
  • Extracorporeal Liver Support - J.A. Wendon
  • CRRT and ECMO - A. Shaw

Session 5: Biomarkers of AKI

  • AKI Biomarkers: Which One? How to Use Them? - M. Haase
  • Does Renal Functional Reserve Exist in ICU Patients? - R. Bellomo
  • Biomarkers and AKI Prevention - J. Kellum
  • Biomarker-Driven Change in AKI Therapy - N. Gibney

Session 6: AKI - Pathophysiology, Prevention, Recovery, Progression

  • Septic Kidney Injury: Update on Pathophysiology - B. Molitoris
  • Prevention of AKI: What Evidence? - M. Joannidis
  • Pathways of Renal Recovery or Progression after AKI - R. Mehta
  • Modality of Artificial Renal Support and Renal Recovery - R. Bellom
  • Ischemic Preconditioning - J. Kellum

Session 7: CardioRenal Crosstalk 

  • AKI after Acute Myocardial Infarction: Contrast, Organ Crosstalk and Complications - P. McCullough
  • Importance of Congestion and Diastolic Dysfunction - M. Säemann
  • Uric Acid as a risk factor for heart and kidney therapeutic management - C. Ronco
  • Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights into Prevention and Clinical Management - P. McCullough
  • New Therapeutic Strategy of Aquaresis for Cardiorenal Syndrome - K. Doi

Session 8: Fluid management

  • Fluid Assessment, Outcomes and Strategies in the Critically Ill - R. Mehta
  • Balanced Fluid or Saline? - R. Bellomo
  • Use of Diuretics in the Critically Ill and CRS - L.S. Chawla
  • Indications to Medical Fluid Removal in HF and Fluid Overload - M. Ostermann

Session 9: Critical Care Nephrology Issues

  • A case study using Lectin-Affinity Plasmapheresis in the Treatment of Ebola Virus Disease - R. Kenley
  • AKI in Trauma: Rhabdomyolysis & Burms - F. Mariano
  • Sorbent Therapy and Endotoxin Removal - C. Ronco
  • Renal Outcomes after Cardiac Surgery - A. Shaw
  • High Cut Off Membranes - G. Villa
  • Citrate vs Heparin vs No Anticoagulation - P. Honoré
  • RRT in Critically Ill Children and Neonates - S. Goldstein

Session 10: New Horizons in AKI and CRRT

  • Hypothermia & the Kidney - S. De Rosa
  • Nomenclature for RRT in AKI - J. Cerda
  • From the Italian Survey: the IRRIV Score - J. Zaragoza
  • Metabolic Alkalosis in the ICU - M. Emmett

 

Additional Info

  • Language: English
  • Contains Audio: Yes
  • Content Type: Presentations
  • Source: Other sources
  • Event: Other events
  • Year: 2015
  • Members Only: No
Read 2006 times Last modified on Thursday, 04 August 2016 20:23

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact